Taisho Pharmaceutical Holdings Co Ltd:戦略・SWOT・企業財務分析

◆英語タイトル:Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015717
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Taisho Pharmaceutical Holdings Co Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Taisho Pharmaceutical Holdings Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Taisho Pharmaceutical Holdings Co Ltd (Taisho Pharmaceutical) is a pharmaceutical company. The company is involved in the development, manufacture and marketing of various pharmaceutical products. The company’s products include self-medication drugs and prescription pharmaceutical. Its self-medication products are marketed under the brand names, including pabron, lipovitan D, riup, livita, naron, colac, zena and among others. Self-Medication also offers real estate leasing, facility management and hotel management services. The company also offer products under the brand names such as include zosyn, clarith, edirol, palux, ozex, geninax, lorcam, pentcillin, tomiron and among others. The company sells macrolide antibiotic clarith through Abbott Laboratories in the US. It distributes products through its subsidiaries located in the Philippines, Indonesia, Malaysia, Thailand, Vietnam, China, Hong Kong, Taiwan, and the US. Taisho Pharmaceutical is headquartered in Tokyo, Japan.

Scope

- Detailed information on Taisho Pharmaceutical Holdings Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Taisho Pharmaceutical Holdings Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Taisho Pharmaceutical Holdings Co Ltd including a breakdown and examination of key business segments
- Intelligence on Taisho Pharmaceutical Holdings Co Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Taisho Pharmaceutical Holdings Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Taisho Pharmaceutical Holdings Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Taisho Pharmaceutical Holdings Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Taisho Pharmaceutical Holdings Co Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Taisho Pharmaceutical Holdings Co Ltd: Company Overview
Taisho Pharmaceutical Holdings Co Ltd: Overview and Key Facts
Taisho Pharmaceutical Holdings Co Ltd: Overview
Taisho Pharmaceutical Holdings Co Ltd: Key Facts
Taisho Pharmaceutical Holdings Co Ltd: Key Employees
Taisho Pharmaceutical Holdings Co Ltd: Key Employee Biographies
Taisho Pharmaceutical Holdings Co Ltd: Major Products and Services
Taisho Pharmaceutical Holdings Co Ltd: Company History
Taisho Pharmaceutical Holdings Co Ltd: Management Statement
Taisho Pharmaceutical Holdings Co Ltd: Locations and Subsidiaries
Taisho Pharmaceutical Holdings Co Ltd: Key Competitors
Taisho Pharmaceutical Holdings Co Ltd: Company Analysis
Taisho Pharmaceutical Holdings Co Ltd: Business Description
Taisho Pharmaceutical Holdings Co Ltd: SWOT Analysis
Taisho Pharmaceutical Holdings Co Ltd: SWOT Overview
Taisho Pharmaceutical Holdings Co Ltd: Strengths
Taisho Pharmaceutical Holdings Co Ltd: Weaknesses
Taisho Pharmaceutical Holdings Co Ltd: Opportunities
Taisho Pharmaceutical Holdings Co Ltd: Threats
Taisho Pharmaceutical Holdings Co Ltd: Corporate Financial Deals Activity
Taisho Pharmaceutical Holdings Co Ltd: Financial Deals Overview
Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners
Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2013 – 2017YTD*
Taisho Pharmaceutical Holdings Co Ltd: Mergers and Acquisitions
Taisho Pharmaceutical Holdings Co Ltd: Partnership
Taisho Pharmaceutical Holdings Co Ltd: Recent Developments
Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary
Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Taisho Pharmaceutical Holdings Co Ltd: Key Facts
Table 2: Taisho Pharmaceutical Holdings Co Ltd: Key Employees
Table 3: Taisho Pharmaceutical Holdings Co Ltd: Locations and Subsidiaries
Table 4: Taisho Pharmaceutical Holdings Co Ltd: Key Competitors
Table 5: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Taisho Pharmaceutical Holdings Co Ltd: M&A Average Deal Size - Value (US$m)
Table 7: Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners
Table 8: Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2013 - 2017YTD*
Table 9: Taisho Pharmaceutical Holdings Co Ltd: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: Taisho Pharmaceutical Holdings Co Ltd: M&A Activity by Geography (2013 - YTD*2017)
Table 11: Taisho Pharmaceutical Holdings Co Ltd: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 12: Taisho Pharmaceutical Holdings Co Ltd: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 13: Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary
Table 14: Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events

★海外企業調査レポート[Taisho Pharmaceutical Holdings Co Ltd:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Angelique International Ltd:企業の戦略・SWOT・財務情報
    Angelique International Ltd - Strategy, SWOT and Corporate Finance Report Summary Angelique International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ferroglobe PLC (GSM):企業の財務・戦略的SWOT分析
    Ferroglobe PLC (GSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Medical Depot Inc-医療機器分野:企業M&A・提携分析
    Summary Medical Depot Inc (Drive Medical) is a medical device company that manufactures and markets mobility products. The company offers products such as rollators, walkers, canes and crutches; bath safety, commodes, wheelchairs, patient room, beds, power mobility, pressure prevention, electrothera …
  • Dominion Energy Inc (D):企業の財務・戦略的SWOT分析
    Dominion Energy Inc (D) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • McKesson Corp (MCK):医療機器:M&Aディール及び事業提携情報
    Summary McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes pharmaceuticals, medical equipment, and health and beauty care products in North America and overseas. The company also develops and provides decision support software and syste …
  • Tejas Networks Ltd (TEJASNET):企業の財務・戦略的SWOT分析
    Tejas Networks Ltd (TEJASNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Novita Healthcare Ltd (NHL):企業の財務・戦略的SWOT分析
    Novita Healthcare Ltd (NHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Volkswagen AG:企業の戦略・SWOT・財務情報
    Volkswagen AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • OJSC Rosneft Oil Company:企業の戦略・SWOT・財務分析
    OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report Summary OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • INFINITT Healthcare Co., Ltd (071200):企業の財務・戦略的SWOT分析
    INFINITT Healthcare Co., Ltd (071200) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Vivimed Labs Ltd (VIVIMEDLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world. The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals. It manufacture …
  • Aegean Marine Petroleum Network Inc (ANWWQ):企業の戦略的SWOT分析
    Aegean Marine Petroleum Network Inc (ANWWQ) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Cellectis SA (ALCLS):医療機器:M&Aディール及び事業提携情報
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • The Rank Group Plc (RNK):企業の財務・戦略的SWOT分析
    The Rank Group Plc (RNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Phenex Pharmaceuticals AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Phenex Pharmaceuticals AG (Phenex Pharmaceuticals) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services such as NR selectivity screening, contract screening services, and SNuRM profiling to pharmaceutical …
  • The Israel Electric Corporation Ltd:企業の戦略的SWOT分析
    The Israel Electric Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • LG Corp (003550):企業の財務・戦略的SWOT分析
    LG Corp (003550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mistras Group Inc (MG):企業の財務・戦略的SWOT分析
    Summary Mistras Group Inc (Mistras) is a provider of technology-enabled asset protection solutions that offers used to evaluate the structural integrity of critical energy, industrial and public infrastructure. The company provides products such as acoustic emission, ultrasonic, and vibration and Pd …
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):企業の財務・戦略的SWOT分析
    Summary Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (Guangzhou Baiyunshan Pharmaceutical) is a manufacturer of herbal medicine, chemical raw material medicine and preparation, biological medicine, and health products. The company also offers health medicines, health beverages, Chinese and we …
  • Energy Resources of Australia Ltd. (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd. (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆